LGALS3 and melanoma: Importantly, Gal-3-treated EVCtrl cells exhibited greater migratory ability than Gal-3-treated GCNT2OE cells (p < 0.05) (Figure 2d), suggesting that I-branching glycosylation attenuates the pro-migratory effects of extracellular Gal-3 on melanoma cells.